Aurobindo Pharma Limited announced mixed performance during the quarter ended June 2025. The business reported a consolidated net profit of ₹824.20 Crore in the quarter under review, down by 10.20% on ...

PNB Housing Finance shares are banned from F&O trading on 5 August 2025.

Aurobindo Pharma's net profit fell 10.2 per cent Y-o-Y to ₹824 crore in Q1FY26, as against ₹918 crore in the same quarter ...

Mumbai :Aurobindo Pharma Limited on Monday reported a 10.2 per cent year-on-year (YoY) drop in consolidated net profit to Rs ...

Stocks including Paytm, Aditya Infotech, Bosch, Laxmi India Finance, Aurobindo Pharma, DLF, Bharti Airtel, Siemens Energy and ...

GIFT Nifty Futures were trading down marginally by 17 points at 24,767, indicating a flat or slight negative opening.

Domestic equity benchmarks halted a two-day losing streak amid buying in IT, energy and auto shares on Monday, though selling ...

Track top stocks like Tata Motors, IndusInd Bank, Kaynes Tech, and more as key updates and earnings could drive action ...

Aurobindo Pharma's Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA), margins and net profit was also ...

AUROBINDO PHARMA LTD - Corporate Action-Board approves Dividend - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts ...

A record date is set by the company to determine which shareholders are eligible to receive the dividend. If your name is on ...